March 29 , 2022

Update on the European Medicines Agency activities

The European Medicines Agency organised an online joint meeting for patient organisations and healthcare professionals on 2^nd and 3^rd March 2022.

In the agenda, there were several very relevant topics such as:

• Information on the role of the EMA in the development and evaluation of advanced therapeutic medicinal products. A very informative and interesting session recommended for all those interested in learning more on advanced therapeutics, such as Strimvelis. The presentation is available here.
• Covid-19: update from EMA representatives on the development of vaccines and therapeutics to treat COVID-19 and an update on the safety from already approved vaccines and medicines.
• Discussion on EMA’s extended mandate: the Agency has seen its mandate extended to include the monitoring of shortages of medicines and devices, providing scientific advice, reviewing clinical-trial protocols, and rolling reviews during public-health emergencies. More information is available on the presentation.
• In the section on members’ voices, Jose Drabwell introduced the participants to PID Life Index.

More information on the meeting as well as the presentations can be found here.